Skip to content

Infant Formula in Infants and Children With Cow's Milk Allergy

Determination of Hypoallergenicity of an Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06456541
Enrollment
96
Registered
2024-06-13
Start date
2024-10-01
Completion date
2029-01-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cow's Milk Allergy

Brief summary

This is a multi-center, randomized, double-blinded, placebo-controlled food challenge to be conducted in infants and children with confirmed IgE-mediated cow's milk allergy (CMA), followed by a 7-day open feeding of the experimental formula.

Interventions

Experimental powder formula

Placebo powder formula

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 12 Years
Healthy volunteers
No

Inclusion criteria

* Participant's parent(s) is/are willing for their child to undergo confirmatory testing or must have had at least one of the following within 6 months of enrollment: 1. Physician diagnosis of IgE-mediated CMA, according to the participant's clinical history (e.g. gastrointestinal symptoms, hives, respiratory symptoms or angioedema) AND, detectable serum milk-specific IgE \>0.7 kUᴀ/L or positive skin prick test wheal ≥5 mm; 2. Documentation of milk-specific serum IgE ≥15 kUᴀ/L or ≥ 5 kUᴀ/L if younger than 1 year; 3. Documented cow's milk skin prick test wheal ≥8mm; 4. Physician-supervised oral food challenge that elicited immediate, objective, allergic symptoms. * Participant's parent(s) agree for their child to stop oral steroid use within 14 days and antihistamine use within 7 days prior to confirmation of diagnosis and food challenges. * Participant had followed a strict cow's milk protein-free diet for at least 2 weeks prior to enrollment. * Parent(s) confirm their intention not to administer any products containing cow's milk protein during the study. * Participant is between 3 months and 12 years of age at enrollment. * Participant's parent(s) has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study.

Exclusion criteria

* Participant is partially or exclusively breastfed at the time of enrollment. * Participant is consuming an amino acid-based formula due to failure on an extensively hydrolyzed formula. * Significant chronic medical diseases including major chromosomal or congenital anomalies, gastrointestinal diseases, or abnormalities other than CMA, immunodeficiencies, unstable asthma, eczema and/or food allergies treated with biologics (omalizumab or other monoclonal antibody), FPIES, eosinophilic esophagitis, and severe uncontrolled eczema. * Previous severe anaphylactic reaction to cow's milk within the last two years., * An adverse medical history or current condition that is thought by the investigator to have potential for effects on tolerance or the hypoallergenicity test. * Participant has an allergy or intolerance to any ingredient in the study product, as reported by the parent. * Participant is consuming baked milk products. * Use of and/or changing dose of high potency steroids. * Participant is treated with any oral immunotherapy (sublingual, subcutaneous, and epicutaneous) for any food allergy.

Design outcomes

Primary

MeasureTime frameDescription
Food Challenge ReactionsFood Challenge 1 to Food Challenge 2 (within 14 days of the Food Challenge 1) (followed by 7 days of feeding the experimental formula at home.)Percent of positive food challenge reactions to the experimental formula administered to cow's milk allergic infants and children.

Secondary

MeasureTime frameDescription
Volume of Experimental Formula IntakeHome Feeding Day 1 to Day 7Parent completed diaries of Intake
Food Intake during StudyHome Feeding Day 1 to Day 7Parent completed daily food diaries
Gastrointestinal SymptomsHome Feeding Day 1 to Day 7Parent completed diaries
Medication UseHome Feeding Day 1 to Day 7Parent completed diaries
Food Challenge Positive ReactionsHome Feeding Day 1 to Day 7Percent of positive food challenge reactions to the experimental formula

Countries

United States

Contacts

CONTACTKristen DeLuca
kristen.deluca@abbott.com6145653522
CONTACTJane Schlezinger
jane.schlezinger@abbott.com+44 (0) 1628 77355

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026